Alexander Valdman

Alexander Valdman

Affiliated to Research | Docent
Visiting address: M1:01 Anna Steckséns väg 41, 17177 Solna
Postal address: K7 Onkologi-Patologi, K7 Forskning Tedgren Valdman, 171 77 Stockholm
Part of:

About me

  • In 2005, I defended my doctoral thesis on prostate cancer at Karolinska Institutet. After a postdoc period at Johns Hopkins in Baltimore, USA in 2006-2007, I returned to the Radiumhemmet at Karolinska University Hospital where I became a specialist in oncology in 2012 and later an associate professor in oncology at Karolinska Institutet. My research area is radiotherapy of pelvic tumors. My research focuses on studying the clinical effects of different types of radiotherapy that can give patients a more effective oncological treatment with favorable side effect profile.

Research

  • Ansvarig huvudprövare (PI) för forskningsstudien PRORECT (NCT04525989)
    www.prorect.se

Articles

All other publications

Grants

  • Swedish Cancer Society
    1 January 2022
    Since the 1990s, the treatment results for rectal cancer have improved significantly in Sweden. The main reasons are improvement of the surgical technique and that an increasing proportion of patients receive preoperative radiotherapy. Several randomized studies have shown that preoperative radiotherapy reduces the risk of local recurrence by at least half. The knowledge about the effects and side effects of radiotherapy is based on studies done 10-30 years ago. Under it in the last decade, there has been a noticeable technological development in the area. Currently, however, there are no randomized ones studies on proton therapy in locally advanced rectal cancer. Today, to a much greater extent than before, the radiation dose can be limited to the body volumes that contain it tumor cells. This results in fewer side effects, as these side effects depend on the radiation dose given and treatment volume. A way to further reduce the dose to adjacent normal tissue and thereby reduce side effects is to give treatment with protons at the national proton therapy department Skandion Clinic. This one study intends to compare whether radiation therapy with protons causes less toxicity (side effects) compared to photons in patients with rectal cancer at high risk of recurrence. Treatment with proton radiation can be controlled more precisely than conventional radiation with photons, which can reduce the risk of side effects. However, the effect of proton irradiation in the treatment of rectal cancer is not clearly mapped. The purpose with this national study is to investigate whether radiotherapy with protons can reduce side effects compared to the standard treatment for high-risk rectal cancer. The study may be the basis for introducing proton radiation as a new standard for this patient group.

Employments

  • Affiliated to Research, Department of Oncology-Pathology, Karolinska Institutet, 2025-2027
  • Senior Research Specialist, Department of Oncology-Pathology, Karolinska Institutet, 2022-2024

Degrees and Education

  • Docent, Karolinska Institutet, 2021
  • Doctor Of Philosophy, Department of Molecular Medicine and Surgery, Karolinska Institutet, 2005
  • Licentiate Degree, Dept of Surgical Science, Karolinska Institutet, 2003

News from KI

Events from KI